John A. Thompson, MD, is Medical Director of the Phase I Clinical Trials Program at the Fred Hutchinson Cancer Center. He also is a professor in the Medical Oncology Division at the University of Washington School of Medicine and a member of the Clinical Research Division at Fred Hutchinson Cancer Center.

Dr. Thompson received his medical degree from the University of Alabama at Birmingham. He completed an internship and residency in internal medicine and a fellowship in oncology at the University of Washington.

Dr. Thompson is a member of several professional organizations, including the American Society of Clinical Oncology, the American Association for Cancer Research, the Society for Immunotherapy of Cancer, and the National Kidney Cancer Association. He has authored or co-authored more than 200 articles, which have appeared in publications such as Journal of Immunology, Blood, Journal of Clinical Oncology, Clinical Cancer Research, and the Journal of National Comprehensive Cancer Center (JNCCN).

Dr. Thompson is Chair of the NCCN Management of Immunotherapy-Related Toxicity Panel.